Reported Standalone quarterly numbers for Vivanza Biosciences are:Net Sales at Rs 0.17 crore in March 2025 down 92.62% from Rs. 2.30 crore in March 2024.
Story continues below Advertisement
Quarterly Net Loss at Rs. 0.97 crore in March 2025 down 155.4% from Rs. 0.38 crore in March 2024.
EBITDA stands negative at Rs. 0.88 crore in March 2025 down 450% from Rs. 0.16 crore in March 2024.
Vivanza Bio shares closed at 2.12 on May 12, 2025 (BSE) and has given -50.23% returns over the last 6 months and -67.53% over the last 12 months.
| Vivanza Biosciences | | Standalone Quarterly Results | in Rs. Cr. |
|
| Mar'25 | Dec'24 | Mar'24 | | Net Sales/Income from operations | 0.17 | 0.76 | 2.30 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 0.17 | 0.76 | 2.30 | | EXPENDITURE | | Consumption of Raw Materials | -- | -- | -- | | Purchase of Traded Goods | 0.17 | 0.75 | 2.03 | | Increase/Decrease in Stocks | 0.70 | -0.29 | 0.24 | | Power & Fuel | -- | -- | -- | | Employees Cost | 0.11 | 0.07 | 0.07 | | Depreciation | 0.00 | 0.00 | 0.01 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 0.09 | 0.11 | 0.09 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | -0.90 | 0.12 | -0.15 | | Other Income | 0.02 | 0.01 | -0.03 | | P/L Before Int., Excpt. Items & Tax | -0.88 | 0.13 | -0.17 | | Interest | 0.08 | 0.09 | 0.09 | | P/L Before Exceptional Items & Tax | -0.96 | 0.04 | -0.27 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | -0.96 | 0.04 | -0.27 | | Tax | 0.00 | -- | 0.11 | | P/L After Tax from Ordinary Activities | -0.97 | 0.04 | -0.38 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -0.97 | 0.04 | -0.38 | | Equity Share Capital | 4.00 | 4.00 | 4.00 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -0.24 | 0.01 | -0.09 | | Diluted EPS | -0.24 | 0.01 | -0.09 | | EPS After Extra Ordinary | | Basic EPS | -0.24 | 0.01 | -0.09 | | Diluted EPS | -0.24 | 0.01 | -0.09 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
